MDoutlook is a leading disease intelligence company.
We build the success of your organization through better decision-making.


Specializing in oncology, rare and ultra-rare diseases, we answer your business questions using custom market research instruments, our proprietary disease panels, our client side experience and our depth of clinical understanding.


Driven by staff medical experts, our team engages with ThoughtLeaders and the right clinicians to deliver real-world, actionable insights.


Our solutions
MDoutlook provides custom and syndicated market research, ThoughtLeader identification and network mapping, and guaranteed physician engagement.


Click on the above icons to explore how our clients derive value.

What's New at MDoutlook

2019 Leadership Study in Oncology & ImmunoOncology

13 Feb 2019

Later this month, MDoutlook will release results from the latest wave of their global leadership study. Using ONCpulse™, we engaged with a robust sample of…


ONCpulse™ - Precision Oncology In Action

30 Jan 2019

ONCpulse™ recently provided time sensitive feedback from Oncologists’ review of messaging from a TPP project in metastatic Gastric Cancer. Reflecting on the study, the Director…


Exploring the professional networks of Nobel Prize winners

08 Oct 2018

Since 1901 the Nobel Prize for Physiology and Medicine has been awarded to 216 Laureates. In total, 122 different discoveries have been endowed; 36 of which…


What's Trending in Oncology (updated hourly)